NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This publication is provided for historical reference only and the information may be out of date.
Excerpt
This national guideline provides evidence-based recommendations for the primary care management of dyspepsia symptoms and underlying causes in adults. It was developed for use by the National Health Service in England and Wales. NHS healthcare professionals, patient representatives and researchers developed this guideline, incorporating comments received from referees and from an extensive national stakeholder consultation.
The guideline defines dyspepsia broadly and inclusively, reflecting its presentation and management in the primary care setting. Thus, dyspepsia refers to a spectrum of usually intermittent upper gastrointestinal symptoms, including epigastric pain and heartburn. Annually, 40% of the adult population may suffer from dyspepsia, although only about 2% consult their GP. Currently, prescribed drugs and endoscopies alone annually cost the NHS about £600 million; over-the-counter medication cost patients a further £100 million. The evidence review differentiates between uninvestigated dyspepsia and three main categories arising from investigation: gastro-oesophageal reflux disease, peptic ulcer disease and non-ulcer dyspepsia. Further sub-categories are discussed as the evidence allows.
Contents
- Summary
- Overview
- Recommendation overview
- The community pharmacist
- Referral guidance for endoscopy
- Common elements of care
- Interventions for uninvestigated dyspepsia
- Reviewing patient care
- Interventions for gastro-oesophageal reflux disease
- Interventions for peptic ulcer disease
- Interventions for non-ulcer dyspepsia
- Helicobacter pylori testing and eradication
- Methods
- Evidence
- Introduction
- Dyspepsia: definition and prevalence
- Treatments and procedures for dyspepsia
- The community pharmacist
- Common elements of care
- Referral guidance for endoscopy at presentation
- Interventions for uninvestigated dyspepsia
- Reviewing patient care
- Interventions for gastro-oesophageal reflux disease
- Interventions for peptic ulcer disease
- Interventions for non-ulcer dyspepsia
- Helicobacter pylori testing and eradication
- Auditing care
- Future research
- References (Evidence)
- Appendices
- Appendix 1. Describing the results of trials
- Appendix 2. Describing the results of diagnostic tests
- Appendix 3. Prescription cost analysis for dyspepsia-related drugs
- Appendix 4. A cost comparison of serology, stool antigen and breath testing for H. pylori
- Appendix 5. Patients’ and GPs’ views of dyspepsia
- Appendix 6. Randomised controlled trials of therapies for undiagnosed dyspepsia
- Appendix 7. Randomised controlled trials of therapies for gastro-oesophageal reflux disease
- Appendix 8. Economic analyses addressing management of gastro-oesophageal reflux disease (GORD)
- Appendix 9. Randomised controlled trials of therapies for peptic ulcer
- Appendix 10. Economic analyses addressing H. pylori eradication in peptic ulcer disease
- Appendix 11. Randomised controlled trials of therapies for non-ulcer dyspepsia
- Review Dyspepsia and Gastro-oesophageal Reflux: A Systematic Review[ 2007]Review Dyspepsia and Gastro-oesophageal Reflux: A Systematic ReviewSwedish Council on Health Technology Assessment. 2007 Oct
- Are dyspepsia management guidelines coherent with primary care practice?[Scand J Gastroenterol. 2002]Are dyspepsia management guidelines coherent with primary care practice?Cardin F, Zorzi M, Furlanetto A, Guerra C, Bandini F, Polito D, Bano F, Grion AM, Toffanin R. Scand J Gastroenterol. 2002 Nov; 37(11):1269-75.
- Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales.[Aliment Pharmacol Ther. 2005]Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales.Mason JM, Delaney B, Moayyedi P, Thomas M, Walt R, North of England Dyspepsia Guideline Development Group. Aliment Pharmacol Ther. 2005 May 1; 21(9):1135-43.
- Minimal differences in prevalence and spectrum of organic disease at upper gastrointestinal endoscopy between selected secondary care patients with symptoms of gastro-oesophageal reflux or dyspepsia.[Scand J Gastroenterol. 2017]Minimal differences in prevalence and spectrum of organic disease at upper gastrointestinal endoscopy between selected secondary care patients with symptoms of gastro-oesophageal reflux or dyspepsia.Irvine AJ, Pinto-Sanchez MI, Bercik P, Moayyedi P, Ford AC. Scand J Gastroenterol. 2017 Apr; 52(4):396-402. Epub 2016 Dec 15.
- Review Essential Hypertension: Managing Adult Patients in Primary Care[ 2004]Review Essential Hypertension: Managing Adult Patients in Primary CareNorth of England Hypertension Guideline Development Group (UK). 2004 Aug